Hui Xu
- Molecular Biology top 5%
- Cancer Research top 2%
- Biomedical Engineering top 5%
- Oncology top 5%
- Plant Science top 5%
- Topics
- MicroRNA in disease regulation (16 papers)Cancer-related molecular mechanisms research (12 papers)Fungal Biology and Applications (11 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hui Xu
190 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 161
- Molecular Biology 1.9k
- Cancer Research 1.0k
- Biomedical Engineering 545
- Oncology 479
- Plant Science 397
Countries citing papers authored by Hui Xu
This map shows the geographic impact of Hui Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Xu more than expected).
Fields of papers citing papers by Hui Xu
This network shows the impact of papers produced by Hui Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Xu. The network helps show where Hui Xu may publish in the future.
Co-authorship network of co-authors of Hui Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Xu. A scholar is included among the top collaborators of Hui Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Xu. Hui Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 8 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 9 | |
| 12 | 1 | |
| 13 | 7 | |
| 14 | 2 | |
| 15 | 4 | |
| 16 | 9 | |
| 17 | Polysaccharide, a Potential Anti-Cancer Drug with High Efficacy and Safety | 9 |
| 18 | 直腸癌術後患者の社会心理適応能力に対する同心会活動の影響【JST・京大機械翻訳】 | 1 |
| 19 | Variations of in vitro Tetramethylpyrazine Permeation Through Human Skin of Different Body Regions | 1 |
| 20 | RTI‐4614‐4 μ対δオピオイド結合部位に27000倍の結合選択性を有する(+)‐シス‐3‐メチルフェンタニルの誘導体 | 3 |
About Hui Xu
Hui Xu is a scholar working on Cancer Research, Pharmacology and Microbiology, having authored 214 papers that have together received 4.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (12 papers) and Fungal Biology and Applications (11 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (1.9k citations) and Pharmacology (379 citations). Hui Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hui Zhou, Liang‐Hu Qu, Xiaojuan Xu, Jianhua Qin, Shu‐Juan Xie, Mianbo Huang, Qing Yao, Siwei Zou, Qianqian Zhang and Lina Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.